Nasogastric Tube in Pancreatic Surgery
Nasogastric Tube in Pancreatic Surgery
Introduction: The value of routine nasogastric tube (NGT) decompression after pancreatic
 surgeries is not yet established. Previous studies in the setting of abdominal surgery
 suggested that the use of NGT does not accomplish any of its intended goals.

 Methods/design: This is a prospective, randomized, controlled multicenter trial with two
 treatment arms. One group underwent pancreatic surgeries with routine NGT and was left in
 place after surgery until the patient passed flatus or stool. The other group underwent
 pancreatic surgeries without receiving NGT decompression, in which the NGT was removed at the
 end of surgery.

 Discussion: Routine NGT decompression after pancreatic surgeries does or does not appear to
 have its anticipated advantages would be discovered in this RCT.
Inclusion Criteria:

 -  Patients with age between 18 - 80 years.

 -  Patients underwent any kind of pancreatic surgeries, including but not limited to PD,
 distal pancreatectomy, central pancreatectomy, pancreatic enucleation, etc.

 -  Patients accepted the trial and could completed a written consent.

 Exclusion Criteria:

 -  Combined with digestive tract obstruction before the surgery.

 -  History of upper abdominal surgery.

 -  Serious heart, brain, lung, metabolic diseases history.

 -  Pregnant women.

 -  Unwillingness or inability to consent for the study.